{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-09-09", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "d0167526-c0bd-4834-9cb8-01ae86085bd8", "code": "CJZ26L1EGI", "type": "PRIMARY", "code_system": "FDA UNII" } ], "substance_class": "protein", "references": [ { "uuid": "8c34960a-e76c-4e5c-b521-400f58d4aa94", "citation": "Uttamsingh, Vinita, et al. \"Altering metabolic profiles of drugs by precision deuteration: reducing mechanism-based inhibition of CYP2D6 by paroxetine.\" Journal of Pharmacology and Experimental Therapeutics 354.1 (2015): 43-54.", "url": "http://jpet.aspetjournals.org/content/354/1/43.long", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "96aa8524-dd54-4ddc-a8c0-ef8717ff0188", "citation": "ESCITALOPRAM", "doc_type": "MICROMEDEX", "public_domain": true }, { "uuid": "55b7a0f1-a643-4e06-8e72-e6894dc3cbb6", "citation": "https://www.drugbank.ca/drugs/DB00715", "doc_type": "WEBSITE", "public_domain": true }, { "uuid": "90ec3f7c-8496-4f0a-9028-d3c1f64ce5b0", "citation": "WIKI", "url": "https://en.wikipedia.org/wiki/Litoxetine", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "993010c0-df5f-4755-bc7e-ded9fd87884d", "citation": "FLUOXETINE", "doc_type": "MICROMEDEX", "public_domain": true }, { "uuid": "fb090437-f922-4b9e-ad47-e1f9d3f84a9e", "citation": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c96373f-6744-49d4-aec5-3720bc993fab#nlm34067-9", "url": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c96373f-6744-49d4-aec5-3720bc993fab#nlm34067-9", "doc_type": "DRUG PRODUCT LABEL", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2d227128-7c20-f4d0-044a-71de66f8e581", "citation": "http://www.uniprot.org/uniprot/P31645", "url": "http://www.uniprot.org/uniprot/P31645", "doc_type": "UNIPROT", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8eed7d72-e185-44cf-a4d7-638fbdf8b809", "citation": "System Generated Code", "doc_type": "SRS", "public_domain": true }, { "uuid": "6d491c46-85c1-1829-6200-da2b13f7bd14", "citation": "208447Orig1s000 MULTI-DISCIPLINE REVIEW", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208447Orig1s000MultidisciplineR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true }, { "uuid": "8f28f893-9200-4036-b901-4808867d5dc3", "citation": "Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). \"Pharmacological profile of antidepressants and related compounds at human monoamine transporters\". European Journal of Pharmacology. 340 (2–3): 249–58. doi:10.1016/s0014-2999(97)01393-9. PMID 9537821", "url": "https://www.sciencedirect.com/science/article/pii/S0014299997013939?via%3Dihub", "doc_type": "JA", "public_domain": true }, { "uuid": "b0df70a7-2a4c-407d-ad74-190ccec6a167", "citation": "EUR J CLIN PHARMACOL (2001) 57: 653-658", "url": "http://medlibrary.org/lib/rx/meds/fluvoxamine-maleate-extended-release-1/page/9/", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "0c22361b-3adf-4be7-bd85-eb82030e92c6", "citation": "Kato, Taro, et al. \"DSP‐1053, a novel serotonin reuptake inhibitor with 5‐HT1A partial agonistic activity, displays fast antidepressant effect with minimal undesirable effects in juvenile rats.\" Pharmacology Research & Perspectives 3.3 (2015)", "url": "https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.142", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e589cb11-c09e-42dd-b0b9-d490a87d3ede", "citation": "Saha, Kusumika, et al. \"The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates.\" Psychopharmacology 236.3 (2019): 953-962.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476708/pdf/nihms-1510215.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "dcbbf132-8fd4-4292-bf56-8d9ac255dd9f", "citation": "Saha, Kusumika, et al. \"The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates.\" Psychopharmacology 236.3 (2019): 953-962.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476708/pdf/nihms-1510215.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "4cb2f3a8-80a0-453f-967b-94edd171c8b9", "citation": "López‐Arnau, Raul, et al. \"Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.\" British journal of pharmacology 167.2 (2012): 407-420.", "url": "https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/j.1476-5381.2012.01998.x?casa_token=I2e3iKAo3nUAAAAA%3AIF7AVMAPgE0xKoxQrSEPGqNTNyPCFSaHlitjyIgsaORlapM1XKoOqwl9PRDsUPL9ArxD5PTVvl0XAAI", "doc_type": "JA", "public_domain": true }, { "uuid": "10737115-99e9-4705-8149-70885179679d", "citation": "Shin, Dongseong, et al. \"Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects.\" Drug Design, Development and Therapy 11 (2017): 713.", "url": "Shin, Dongseong, et al. \"Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects.\" Drug Design, Development and Therapy 11 (2017): 713.", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1359d479-dd06-4c68-9956-baf5634c0719", "citation": "Grond, Stefan, and Armin Sablotzki. \"Clinical pharmacology of tramadol.\" Clinical pharmacokinetics 43.13 (2004): 879-923.", "url": "https://link.springer.com/article/10.2165/00003088-200443130-00004", "doc_type": "JA", "public_domain": true }, { "uuid": "5af911c5-ec9d-4d12-ac20-beced4700fc8", "citation": "Grond, Stefan, and Armin Sablotzki. \"Clinical pharmacology of tramadol.\" Clinical pharmacokinetics 43.13 (2004): 879-923.", "url": "https://link.springer.com/article/10.2165/00003088-200443130-00004", "doc_type": "JA", "public_domain": true }, { "uuid": "da892325-407b-4661-a354-75a21592cba6", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/209500Orig1s000MultidisciplineR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "3f0ebd3c-2cd9-43e3-bec4-293e002c2ab7", "citation": "Sabatucci, Joseph P., et al. \"Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.\" Bioorganic & medicinal chemistry letters 20.9 (2010): 2809-2812.", "url": "https://www.sciencedirect.com/science/article/pii/S0960894X1000380X?via%3Dihub", "doc_type": "JA", "public_domain": true }, { "uuid": "ea4806fe-ce3f-45c3-a877-34a0a7daac44", "citation": "Huang, Yiyun, et al. \"A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C] 2-[2-(dimethylaminomethyl) phenylthio]-5-fluoromethylphenylamine ([11C] AFM).\" Nuclear medicine and biology 31.5 (2004): 543-556.", "url": "https://www.sciencedirect.com/science/article/pii/S0969805104000034", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2b35edf1-478d-444b-9f86-40d5c42d95a4", "citation": "Grond, Stefan, and Armin Sablotzki. \"Clinical pharmacology of tramadol.\" Clinical pharmacokinetics 43.13 (2004): 879-923.", "url": "https://link.springer.com/article/10.2165/00003088-200443130-00004", "doc_type": "JA", "public_domain": true }, { "uuid": "c1a8ee1b-d87e-42e3-90c2-2e6480cb1822", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "d4768f98-e05c-4e58-86d7-3958dbfee941", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c69b6f2a-2269-4654-94f3-912717dada02", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "d375b92d-f0ac-4db9-984e-3463368d230f", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "608161f9-91a5-4b76-827b-e0cdbd65b6c6", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "aad77066-8935-4cc3-b8d4-a551d55bbc6a", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "6fbf3402-b162-4b61-a1f0-a985d74e0cf2", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "deb9916e-b015-4cc4-bc35-6f9897342c01", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "cfe2f774-563a-4c9e-98cf-85ecf72d09f1", "citation": "Rothman, Richard B., et al. \"Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: implications for primary pulmonary hypertension.\" Circulation 100.8 (1999): 869-875.", "url": "https://www.ahajournals.org/doi/full/10.1161/01.cir.100.8.869", "doc_type": "JA", "public_domain": true }, { "uuid": "4ffc995d-b41f-4a95-9623-2023c5133a64", "citation": "Rothman, Richard B., et al. \"Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: implications for primary pulmonary hypertension.\" Circulation 100.8 (1999): 869-875.", "url": "https://www.ahajournals.org/doi/full/10.1161/01.CIR.100.8.869", "doc_type": "JA", "public_domain": true }, { "uuid": "76c79aff-4406-4bb7-956a-40376fe0d3b6", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e3bf5daa-6baf-477c-88fe-a537b4d75598", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "f99e499b-059a-4458-bd03-d36c6e1d7294", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "9e733594-fe19-4983-8d24-f870938a66c0", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2d2ef1d0-6bf2-47af-8de2-b9c6ad1ace0e", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "61c9e316-a6fe-4be9-9a03-b1fe3152241f", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "49b89126-4a23-42e0-8ec2-47d21525bf62", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "169f5962-2d4b-4324-86fb-4ea16f9dcbb0", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "0be91a07-018f-4927-b83d-3b10e79611a6", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "0d2c035a-4cc0-4484-9511-da244334a585", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "fd001928-4877-4241-8f6d-063c89f300c8", "citation": "Pullar, Ian A., et al. \"LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone.\" European journal of pharmacology 407.1-2 (2000): 39-46.", "url": "https://www.sciencedirect.com/science/article/pii/S0014299900007287", "doc_type": "JA", "public_domain": true }, { "uuid": "5fc4cf14-81ce-4a71-94fb-cab9e1b39616", "citation": "Rickli, Anna, et al. \"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.\" European Neuropsychopharmacology 26.8 (2016): 1327-1337.", "url": "https://www.sciencedirect.com/science/article/pii/S0924977X16300426", "doc_type": "JA", "public_domain": true }, { "uuid": "853322d2-e641-4da6-8184-46e31c1698e9", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "12bd2ffd-7b85-4693-87b1-f2c41f9a95d9", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "3380b426-e05a-4a2a-b875-91127f37e490", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "3f8ddf2e-84cc-49d9-b4c5-90f61421b34a", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "doc_type": "ASSAY REFERENCE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b7477ef0-5ea1-44e5-bb17-86d5e8fd3234", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "94d8ebde-5c1b-490e-976b-c08997d569b8", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "75dbd778-d2cf-42e2-a213-5111c335010d", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "129ba18a-791e-4428-9e8f-8a822fc30620", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1dd3715a-ac90-4cf9-9543-432904356dd3", "citation": "Iversen, Les, et al. \"Neurochemical profiles of some novel psychoactive substances.\" European journal of pharmacology 700.1-3 (2013): 147-151.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582025/", "doc_type": "JA", "public_domain": true }, { "uuid": "b3af0f7c-6a0f-49e1-be9d-91949b419996", "citation": "https://en.wikipedia.org/wiki/Dextromethorphan", "url": "https://en.wikipedia.org/wiki/Dextromethorphan", "doc_type": "WIKI", "public_domain": true }, { "uuid": "d3aad838-652f-4745-bd62-bbe3b753fd55", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4e348888-06c2-41f7-8691-8b63cf93dc5c", "citation": "Nagai, Fumiko, Ryouichi Nonaka, and Kanako Satoh Hisashi Kamimura. \"The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.\" European journal of pharmacology 559.2-3 (2007): 132-137.", "url": "https://www.sciencedirect.com/science/article/pii/S0014299906013811", "doc_type": "JA", "public_domain": true }, { "uuid": "6c2fbf58-b1a5-468d-96ec-d01a5a3dcb1b", "citation": "Toda, Narihiro, et al. \"Design, synthesis and structure–Activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.\" Bioorganic & medicinal chemistry 11.9 (2003): 1935-1955.", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0968089603000919", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "3b239291-368a-4294-89db-295b5085cdd4", "citation": "Comerma‐Steffensen, Simon, et al. \"A novel reuptake inhibitor, IP2015, induces erection by increasing central dopamine and peripheral nitric oxide release.\" British Journal of Pharmacology (2024).", "url": "https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bph.16362", "doc_type": "JA", "public_domain": true }, { "uuid": "3781604e-d364-4a57-b923-9ca266dde09c", "citation": "Mandrioli, Roberto, and Laura Mercolini. \"Discontinued anxiolytic drugs (2009–2014).\" Expert opinion on investigational drugs 24.4 (2015): 557-573.", "doc_type": "JA", "public_domain": true }, { "uuid": "922531c6-aab5-4938-a713-40e17ff24c32", "citation": "Bös, Michael, et al. \"Synthesis of rel‐(3RS, 3aSR, 7aSR)‐3‐(4‐Chlorophenyl)‐3a, 4, 5, 6, 7, 7a‐hexahydro‐1‐methylindolin‐6‐one, the Main Metabolite of the Analgesic Ro 15‐8081: A Potent Amine‐Uptake Inhibitor.\" Helvetica chimica acta 73.4 (1990): 932-939.", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "35a3a456-778d-4d4f-b9cd-dc2c473f0849", "citation": "Bolnot-Delmas, Dominique, et al. \"Ro 15-8081 in osteoarthritis of hip and knee: a double-blind placebo-controlled multicentre dose-ranging study on analgesia.\" Pain 64.1 (1996): 99-105.", "url": "https://www.sciencedirect.com/science/article/pii/0304395995000755", "doc_type": "JA", "public_domain": true }, { "uuid": "77cfb344-31ec-432a-b182-27abaa5f7529", "citation": "Andrews, Mark D., and Donald S. Middleton. \"The Discovery of UK-390957: the Challenge of Targeting a Short Half-life, Rapid Tmax SSRI.\" Accounts in Drug Discovery. 2010. 142-165.", "doc_type": "JA", "public_domain": true }, { "uuid": "85b2b544-76bb-4c5c-896b-7a3f2e0c6946", "citation": "Polc, P., et al. \"Effect of tricyclic and tetracyclic antidepressants on the sleep-wakefulness cycle of cats.\" Sleep (1976): 380-382.", "doc_type": "MEETING ABSTRACT", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b2f05544-2163-4f6b-97c2-c553d3c799e0", "citation": "Polc, P., J. Schneeberger, and W. Haefely. \"Effects of several centrally active drugs on the sleep-wakefulness cycle of cats.\" Neuropharmacology 18.3 (1979): 259-267.", "url": "https://www.sciencedirect.com/science/article/pii/0028390879901242", "doc_type": "JA", "public_domain": true }, { "uuid": "f4b1da33-4898-4618-b224-5062a832685a", "citation": "Eshleman, Amy J., et al. \"Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release.\" Journal of Pharmacology and Experimental Therapeutics 360.1 (2017): 33-47.", "url": "https://www.ingentaconnect.com/content/ben/cn/2013/00000011/00000005/art00007?crawler=true", "doc_type": "JA", "public_domain": true }, { "uuid": "1ee79933-7b8a-4782-82e6-b9ac680d9778", "citation": "https://www.drugbank.ca/drugs/DB00458", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "7ea81f6d-8053-49bc-9be6-8661e8e452aa", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "doc_type": "ASSAY REFERENCE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "fcb98612-a566-4844-b9cc-00872eacf18c", "citation": "W. Gordon Frankle; Mark Slifstein; Roger N. Gunn; Yiyun Huang; Dah-Ren Hwang; E. Ashlie Darr; Rajesh Narendran; Marc Laruelle (May 1, 2006). \"Estimation of Serotonin Transporter Parameters with 11C-DASB in Healthy Humans: Reproducibility and Comparison of Methods\". Journal of Nuclear Medicine. 47 (5): 815–826. PMID 16644752.", "url": "http://jnm.snmjournals.org/content/47/5/815.long", "doc_type": "JA", "public_domain": true }, { "uuid": "7e697e3b-940a-4791-954b-8ee1c3f8ee9b", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "doc_type": "ASSAY REFERENCE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1c8ac9f5-f10f-4417-9bfd-f72254544bbb", "citation": "Maj, J., et al. \"Pharmacological properties of EXP 561, a potential antidepressant drug.\" Journal of neural transmission 70 (1987): 81-97.", "url": "https://link.springer.com/content/pdf/10.1007/BF01252511.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "a30a6a35-396a-405d-b3d5-f589f57e4e66", "citation": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c96373f-6744-49d4-aec5-3720bc993fab#nlm34067-9", "url": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c96373f-6744-49d4-aec5-3720bc993fab#nlm34067-9", "doc_type": "DRUG PRODUCT LABEL", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "18e6848d-a86e-4125-967b-0a7974ef2a84", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "doc_type": "ASSAY REFERENCE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4dbab1c9-d59b-43aa-ac18-2168fcf8e921", "citation": "FLUOXETINE", "doc_type": "MICROMEDEX", "public_domain": true }, { "uuid": "b72b4d6d-a2c2-438f-9cff-e5cdb5986703", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/439", "doc_type": "ASSAY REFERENCE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "27ba7b34-2d52-4557-ae4b-db6a700bb367", "citation": "Verrico, Christopher D., Gregory M. Miller, and Bertha K. Madras. \"MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.\" Psychopharmacology 189 (2007): 489-503.", "url": "https://link.springer.com/article/10.1007/s00213-005-0174-5", "doc_type": "JA", "public_domain": true }, { "uuid": "59b5c977-9c32-4ced-8f6f-b3527a480103", "citation": "https://www.technologynetworks.com/drug-discovery/news/osi-pharmaceuticals-initiates-clinical-development-program-for-antiobesity-candidate-psn602-204555", "url": "https://www.technologynetworks.com/drug-discovery/news/osi-pharmaceuticals-initiates-clinical-development-program-for-antiobesity-candidate-psn602-204555", "doc_type": "WEB PAGE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "cba4597f-34fe-4b64-ba27-575656d512c7", "citation": "https://www.drugbank.ca/drugs/DB09068", "doc_type": "WEBSITE", "public_domain": true } ], "definition_type": "PRIMARY", "definition_level": "COMPLETE", "uuid": "06df8044-d6c0-4403-85ab-26c75e41e405", "version": "104", "unii": "CJZ26L1EGI", "relationships": [ { "uuid": "a00837cb-a92f-4753-ae46-b5a72577d475", "amount": { "uuid": "f566eb7d-dea8-490b-8c17-af2c96c94a3c", "average": 4.3, "units": "MICROMOLAR" }, "qualification": "IC50", "type": "SUBSTRATE->TARGET", "interaction_type": "BINDING", "references": [ "7e697e3b-940a-4791-954b-8ee1c3f8ee9b" ], "related_substance": { "uuid": "8a558e5e-fa54-477c-bf6a-ceb8bd9e6563", "refuuid": "d15c41a6-62d9-4cec-8179-174e4359c2e1", "name": "Serotonin", "unii": "333DO1RDJY", "linking_id": "333DO1RDJY", "ref_pname": "Serotonin", "substance_class": "reference" } }, { "uuid": "c6dd2624-059a-4048-b25f-995667ca645f", "type": "LIGAND->BINDER", "related_substance": { "uuid": "acac311c-439e-44ca-ae42-0cf9fbc81b1e", "refuuid": "d8a9ee86-c46d-45d2-9e34-3332511b7db2", "name": "DASB", "unii": "PP549Z0645", "linking_id": "PP549Z0645", "ref_pname": "DASB" } }, { "uuid": "ef21c2d4-052b-4af8-94d2-99ab481a8b44", "amount": { "uuid": "456ba8d4-eaf6-4d73-ac57-0a9b71581d52" }, "type": "TARGET->RADIOLIGAND", "references": [ "fcb98612-a566-4844-b9cc-00872eacf18c" ], "related_substance": { "uuid": "ec51b3eb-df1d-4ae9-9c45-38d1ea278ff4", "refuuid": "9cc4ca3c-36ae-43e6-8b13-478645902867", "name": "DASB C-11", "unii": "FJU46Q2BPU", "linking_id": "FJU46Q2BPU", "ref_pname": "DASB C-11" } }, { "uuid": "6d8378fd-b61d-4caf-b290-ea222e1b0360", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "d04c1de5-3473-46d7-9f28-72451e56beb0", "refuuid": "72cf8b31-db34-4a56-9158-1340e3028389", "name": "Duloxetine", "unii": "O5TNM5N07U", "linking_id": "O5TNM5N07U", "ref_pname": "Duloxetine" } }, { "uuid": "27ecba88-92a6-48aa-8251-8161527fae1a", "amount": { "uuid": "d06c85f2-ea9d-4a42-8a16-31bd521bc167", "average": 363, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "interaction_type": "IN-VITRO", "references": [ "6d491c46-85c1-1829-6200-da2b13f7bd14" ], "related_substance": { "uuid": "3c5aa16a-ae0a-4518-8ff8-8bffb4a70aef", "refuuid": "ed2b6e8e-2f51-4b2b-9ad7-80fd4f4c850d", "name": "NIRAPARIB", "unii": "HMC2H89N35", "linking_id": "HMC2H89N35", "ref_pname": "NIRAPARIB", "substance_class": "reference" } }, { "uuid": "1abdd95b-a044-4dd7-9ed4-1197efb66226", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "5ab6e8ff-9296-4366-adbb-8f613eb1c76a", "refuuid": "ad1035e3-bc18-4070-bf61-d4a96bc7c531", "name": "PSEUDOEPHEDRINE", "unii": "7CUC9DDI9F", "linking_id": "7CUC9DDI9F", "ref_pname": "PSEUDOEPHEDRINE" } }, { "uuid": "47a48888-6fdf-4233-9536-89925c856a2d", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "1591ba84-98a7-49b0-beaf-d6e23d9be9db", "refuuid": "9b57a333-0f9a-45c2-8528-c16f6bdaf4fd", "name": "403U76 FREE BASE", "unii": "06KJP8A4M6", "linking_id": "06KJP8A4M6", "ref_pname": "403U76 FREE BASE" } }, { "uuid": "6dfde215-868e-4b2f-8b86-22df9a5af5bd", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "96ef6869-4a27-4e49-91f5-ebac4a2c7a1b", "refuuid": "6895c1d6-8f30-4484-aed3-85bb17351e85", "name": "SERTRALINE", "unii": "QUC7NX6WMB", "linking_id": "QUC7NX6WMB", "ref_pname": "SERTRALINE" } }, { "uuid": "0340f73c-1cc5-4e06-9303-db1c8c3ffed4", "type": "INHIBITOR->TARGET", "references": [ "55b7a0f1-a643-4e06-8e72-e6894dc3cbb6" ], "related_substance": { "uuid": "5b5b7378-5a3c-4b51-9211-9d94096508f1", "refuuid": "62867315-5e42-499b-8ee9-3df84a5dc93e", "name": "PAROXETINE", "unii": "41VRH5220H", "linking_id": "41VRH5220H", "ref_pname": "PAROXETINE" } }, { "uuid": "d0b0aeed-4795-43ad-b4da-b42372a4923e", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "1df2a3b5-6d76-4771-bfed-e002983d924e", "refuuid": "62867315-5e42-499b-8ee9-3df84a5dc93e", "name": "PAROXETINE", "unii": "41VRH5220H", "linking_id": "41VRH5220H", "ref_pname": "PAROXETINE" } }, { "uuid": "96e5fc20-67a5-4480-977d-71192e3cb2e8", "amount": { "uuid": "f013d6bf-b6ec-4118-92ea-ecd70a8eb866", "average": 1.6, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "interaction_type": "BINDING", "references": [ "cba4597f-34fe-4b64-ba27-575656d512c7" ], "related_substance": { "uuid": "0e63c6c5-122f-4753-a46d-d3b839d9b9b6", "refuuid": "8037c5dc-2eea-4de4-b955-4c3c38c6deff", "name": "Vortioxetine", "unii": "3O2K1S3WQV", "linking_id": "3O2K1S3WQV", "ref_pname": "Vortioxetine" } }, { "uuid": "55c38701-c47e-4c4b-bb4c-491708f3c53c", "amount": { "uuid": "3b7e9abd-706b-4f6a-b800-1da18e62a48d" }, "comments": "(+)-Tramadol inhibits serotonin reuptake", "type": "INHIBITOR->TARGET", "references": [ "2b35edf1-478d-444b-9f86-40d5c42d95a4" ], "related_substance": { "uuid": "055c8f55-6dcd-48c5-8e0d-29549d4ef245", "refuuid": "2966d491-86e8-429b-85e9-cd22e4f13278", "name": "TRAMADOL", "unii": "39J1LGJ30J", "linking_id": "39J1LGJ30J", "ref_pname": "TRAMADOL" } }, { "uuid": "4733702e-2386-4f7c-8d4e-4c8d59aac7f5", "type": "INHIBITOR->TARGET", "references": [ "1359d479-dd06-4c68-9956-baf5634c0719" ], "related_substance": { "uuid": "f95cc25e-a322-4dc1-8105-73c2cbb090b9", "refuuid": "c0ea25ba-3b0a-4a7c-83b8-2c3743b619c9", "name": "TRAMADOL, (+)-", "unii": "0NG5TTM63P", "linking_id": "0NG5TTM63P", "ref_pname": "TRAMADOL, (+)-" } }, { "uuid": "a23b7e35-3e77-449f-9b8e-567e4b2240be", "amount": { "uuid": "f2309fa5-136f-4ab1-bbf1-b82ed91c4fc8", "average": 2.2, "high": 2.4, "low": 2, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "INHIBITOR->TARGET", "references": [ "8f28f893-9200-4036-b901-4808867d5dc3", "b0df70a7-2a4c-407d-ad74-190ccec6a167" ], "related_substance": { "uuid": "2eda2b04-9c3c-4bf5-9be1-fafa398d473d", "refuuid": "a002a23e-0b00-4b99-9171-c6fa4dd9ce9c", "name": "FLUVOXAMINE", "unii": "O4L1XPO44W", "linking_id": "O4L1XPO44W", "ref_pname": "FLUVOXAMINE" } }, { "uuid": "84e7d36c-54cf-4a0b-9e1d-1f8e73929f05", "amount": { "uuid": "5f5d34e8-b516-4258-8ad2-1a9ebc8b032e", "average": 3.8, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "interaction_type": "BINDING", "references": [ "a30a6a35-396a-405d-b3d5-f589f57e4e66", "18e6848d-a86e-4125-967b-0a7974ef2a84" ], "related_substance": { "uuid": "1bd4ec4a-49cd-4d76-8a43-4c2760b6470f", "refuuid": "87ac0121-f698-4b47-b330-7a60e77925f3", "name": "CITALOPRAM", "unii": "0DHU5B8D6V", "linking_id": "0DHU5B8D6V", "ref_pname": "CITALOPRAM" } }, { "uuid": "331a9d87-5395-4c14-85b2-0ea72966a690", "type": "INHIBITOR->TARGET", "references": [ "8c34960a-e76c-4e5c-b521-400f58d4aa94" ], "related_substance": { "uuid": "d9316b41-fc40-450d-af70-7df233555be5", "refuuid": "62e1eec7-8a2a-39ea-7039-55d291075204", "name": "CTP-347", "unii": "KP3VT00O7V", "linking_id": "KP3VT00O7V", "ref_pname": "CTP-347" } }, { "uuid": "85bbcf42-2704-4feb-9cf5-0f25325829fd", "type": "INHIBITOR->TARGET", "references": [ "90ec3f7c-8496-4f0a-9028-d3c1f64ce5b0" ], "related_substance": { "uuid": "bb3dc339-f870-4e31-b389-26defb6e990f", "refuuid": "cdde65d4-d71f-4245-bc41-f0c5dc9209fc", "name": "LITOXETINE", "unii": "9980ST005G", "linking_id": "9980ST005G", "ref_pname": "LITOXETINE" } }, { "uuid": "9ffdc276-285d-4fc0-99f4-fa371ac749c9", "amount": { "uuid": "2ba3a4ec-a017-4ed3-8f1d-07e62ddcfba0" }, "type": "INHIBITOR->TARGET", "references": [ "1ee79933-7b8a-4782-82e6-b9ac680d9778" ], "related_substance": { "uuid": "062d8b0a-7400-4fb4-889d-8939f803f18a", "refuuid": "bf549764-98f7-45ac-8e43-9e879aae0754", "name": "IMIPRAMINE", "unii": "OGG85SX4E4", "linking_id": "OGG85SX4E4", "ref_pname": "IMIPRAMINE", "substance_class": "reference" } }, { "uuid": "0d35e57c-2c9f-4b63-833d-7ee773752249", "amount": { "uuid": "3425f56d-faf7-4779-b5b6-c50324cad327" }, "type": "INHIBITOR->TARGET", "references": [ "4dbab1c9-d59b-43aa-ac18-2168fcf8e921" ], "related_substance": { "uuid": "8f993416-4106-415d-b223-21fa2e69bfad", "refuuid": "288a962b-7ef1-4a4e-9cfe-0eb1bb3ce661", "name": "FLUOXETINE", "unii": "01K63SUP8D", "linking_id": "01K63SUP8D", "ref_pname": "FLUOXETINE" } }, { "uuid": "34938270-abf1-4576-81bf-262c6875a7bd", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "fe70c3bc-f36e-476b-8ac4-d22539e518b4", "refuuid": "d7a59c80-f981-4adb-b1d3-87d4df291ffc", "name": "Amitriptyline", "unii": "1806D8D52K", "linking_id": "1806D8D52K", "ref_pname": "Amitriptyline", "substance_class": "reference" } }, { "uuid": "956d9398-a346-4577-86dc-9c79593a2b13", "type": "INHIBITOR->TARGET", "references": [ "96aa8524-dd54-4ddc-a8c0-ef8717ff0188" ], "related_substance": { "uuid": "aa44cd6c-54b3-4262-8451-6ead77904f49", "refuuid": "4b170ecb-6f25-4e1b-93de-29c888bb8a32", "name": "ESCITALOPRAM", "unii": "4O4S742ANY", "linking_id": "4O4S742ANY", "ref_pname": "ESCITALOPRAM" } }, { "uuid": "3286c391-ffa7-4f3d-83e7-b5f188fefffb", "amount": { "uuid": "8d11e4f9-af5e-4dd4-ac51-5ed4874cabf4", "average": 16, "low": 33, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "ANTAGONIST->TARGET", "references": [ "da892325-407b-4661-a354-75a21592cba6" ], "related_substance": { "uuid": "66bbc783-4c5b-4628-ae1a-b65d47f715ec", "refuuid": "7c562b37-d1d2-46e0-8737-abfa9a9a5aec", "name": "Lumateperone", "unii": "70BSQ12069", "linking_id": "70BSQ12069", "ref_pname": "Lumateperone" } }, { "uuid": "3a86ba81-067d-4350-8e03-0fe41606fc22", "amount": { "uuid": "d2895be9-3be4-4d06-839f-b488a88354bb", "average": 27, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "3f0ebd3c-2cd9-43e3-bec4-293e002c2ab7" ], "related_substance": { "uuid": "f636dafa-3996-4c4a-aee4-f82b276826ae", "refuuid": "92ab23e1-a435-47c7-b5a9-3312f26acfe7", "name": "VENLAFAXINE", "unii": "GRZ5RCB1QG", "linking_id": "GRZ5RCB1QG", "ref_pname": "VENLAFAXINE" } }, { "uuid": "ff9b9c37-910b-4629-a8a3-8e6ff1f232c9", "type": "RADIOLIGAND->TARGET", "references": [ "ea4806fe-ce3f-45c3-a877-34a0a7daac44" ], "related_substance": { "uuid": "79b2a48e-99de-4709-8afd-ab30252e61fc", "refuuid": "170564a4-8729-34bd-fc69-6ff8ea90e0b3", "name": "AFM C-11", "unii": "O5LR0V4PLE", "linking_id": "O5LR0V4PLE", "ref_pname": "AFM C-11" } }, { "uuid": "bc3dddc4-6e97-4221-9612-0e808a900d9c", "amount": { "uuid": "0932df89-aeb5-4510-be05-e758058878f5" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "ccc5e3d4-23e8-42b0-9ade-a5a3ebae3f5a", "refuuid": "c44a5d38-3e5a-436b-a4f2-891a65e52063", "name": "IP-2018", "unii": "60XT58V8NZ", "linking_id": "60XT58V8NZ", "ref_pname": "IP-2018" } }, { "uuid": "405cd735-dce0-421d-8ad4-d6eb031ed44e", "amount": { "uuid": "5c427d1f-dec2-4425-8cb2-3d5a24b40bf7" }, "type": "LIGAND->TRANSPORTER", "references": [ "12bd2ffd-7b85-4693-87b1-f2c41f9a95d9" ], "related_substance": { "uuid": "c8fe52f4-4597-45fb-b478-1306fafa708e", "refuuid": "f51c196c-6cf2-4e95-a3ea-435b44b0bd57", "name": "6-FLUORO-DMT", "unii": "J4CZH8D9EN", "linking_id": "J4CZH8D9EN", "ref_pname": "6-FLUORO-DMT" } }, { "uuid": "95ecc009-3ec7-4c1b-9ab5-e41ae1b1890e", "type": "INHIBITOR->TRANSPORTER", "references": [ "6fbf3402-b162-4b61-a1f0-a985d74e0cf2" ], "related_substance": { "uuid": "6abcf9c0-1d54-44c8-847a-f7a7ad9fb05c", "refuuid": "75aa22cb-53eb-4cf0-ad79-88811d78fcc4", "name": "3-METHYL-PCPY", "unii": "FS9Z5C7CQ5", "linking_id": "FS9Z5C7CQ5", "ref_pname": "3-METHYL-PCPY" } }, { "uuid": "fe53d6cb-2a00-4e95-9840-05292001be05", "amount": { "uuid": "baacd954-36ad-4953-8509-e8347cab46a2" }, "type": "INHIBITOR->TRANSPORTER", "interaction_type": "IN RAT", "references": [ "c1a8ee1b-d87e-42e3-90c2-2e6480cb1822" ], "related_substance": { "uuid": "98274012-2a86-4b8e-9a16-182592046ebd", "refuuid": "2aec2653-7f96-4c04-a277-51423c47e131", "name": "6-METHYL-MDA", "unii": "ZXQ5PQR4TU", "linking_id": "ZXQ5PQR4TU", "ref_pname": "6-METHYL-MDA" } }, { "uuid": "21480bf3-085a-4411-a10d-a05d21631e61", "amount": { "uuid": "e6f37f3a-41a9-43d6-8a59-9a11bd913c78" }, "type": "INHIBITOR->TRANSPORTER", "references": [ "75dbd778-d2cf-42e2-a213-5111c335010d" ], "related_substance": { "uuid": "680a04fb-e317-4bda-8160-5d384d193991", "refuuid": "2618bdb1-05e9-4705-a299-59d96ca73c5e", "name": "RTI-120", "unii": "532Y5K4NMA", "linking_id": "532Y5K4NMA", "ref_pname": "RTI-120" } }, { "uuid": "e9776cbe-e6e3-4cfb-bee9-2797e5fd98ae", "amount": { "uuid": "12912a6b-6c78-4b36-b158-9e2cf138f0ed", "average": 811, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "1dd3715a-ac90-4cf9-9543-432904356dd3" ], "related_substance": { "uuid": "cd170274-f551-45ea-b8a9-0d68e753d837", "refuuid": "fb5117e3-c8d9-4411-8c10-10074af28716", "name": "5-APB", "unii": "2M3825704H", "linking_id": "2M3825704H", "ref_pname": "5-APB", "substance_class": "reference" } }, { "uuid": "d4f4ca41-8c54-4fdd-b50a-4a20a6fc9ae9", "amount": { "uuid": "ecbeae8c-7332-4b73-a945-431ec5ab653d", "average": 2400, "units": "NANOMOLAR" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "9cc40ff9-a346-4aa1-9279-26f1ecf3940e", "refuuid": "aa20aecb-9aa8-4711-85fd-136db84f5c43", "name": "5-METHOXY-N,N-DIETHYLTRYPTAMINE", "unii": "52HU7LM8HL", "linking_id": "52HU7LM8HL", "ref_pname": "5-METHOXY-N,N-DIETHYLTRYPTAMINE" } }, { "uuid": "0c861bf7-e342-47c2-bd58-e193fe2477a7", "amount": { "uuid": "7d841570-8bf6-4561-9b1c-c8e44328a6b6" }, "type": "INHIBITOR->TRANSPORTER", "references": [ "b7477ef0-5ea1-44e5-bb17-86d5e8fd3234" ], "related_substance": { "uuid": "873c645c-3e2c-4cc7-94a8-8a594ee0acb5", "refuuid": "7e86cefd-835a-4239-8f54-0bbef7b6ebe7", "name": "JZ-IV-10", "unii": "GYT6ACY5JL", "linking_id": "GYT6ACY5JL", "ref_pname": "JZ-IV-10" } }, { "uuid": "7a385323-aff5-460c-b33b-0f9948bc60cf", "amount": { "uuid": "29ea7857-3f28-45cc-a9d8-cdeaf2e392b1" }, "type": "INHIBITOR->TRANSPORTER", "references": [ "94d8ebde-5c1b-490e-976b-c08997d569b8" ], "related_substance": { "uuid": "d0d80277-6528-4855-be49-a01f33d08de3", "refuuid": "ac43e7aa-ec0e-42ab-9e8d-3c05e6725be0", "name": "1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine", "unii": "3LEH2E7AEU", "linking_id": "3LEH2E7AEU", "ref_pname": "1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine" } }, { "uuid": "17de8f21-a236-45ac-b31b-5334ee6c55bf", "amount": { "uuid": "f797d063-8321-445d-ac18-3ff4b1787969" }, "type": "INHIBITOR->TARGET", "references": [ "76c79aff-4406-4bb7-956a-40376fe0d3b6" ], "related_substance": { "uuid": "70dc0ca1-6e67-4690-8a4d-71063cc83745", "refuuid": "77cd57a5-f55d-429d-8007-8333c364212a", "name": "WF-23", "unii": "7KN3H3NMW6", "linking_id": "7KN3H3NMW6", "ref_pname": "WF-23" } }, { "uuid": "cfebddd5-4d6b-43bd-8b36-97c3219bb532", "amount": { "uuid": "a5fc56ae-f59a-47a8-abfb-86125896b147", "average": 362, "high": 415, "low": 309, "units": "NANOMOLAR" }, "comments": "Inhibition of [3H]Neurotransmitter Uptake. May reverse flow of serotonin leading to release.", "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "f4b1da33-4898-4618-b224-5062a832685a" ], "related_substance": { "uuid": "d19be578-e9f0-4725-816f-d68ac27db0dd", "refuuid": "f4ef2cfe-9693-4135-b4f3-d04a9595a9ac", "name": "MIDOMAFETAMINE", "unii": "KE1SEN21RM", "linking_id": "KE1SEN21RM", "ref_pname": "MIDOMAFETAMINE" } }, { "uuid": "4b1ddc89-cbc6-4305-9ba1-f9784360243e", "amount": { "uuid": "70733207-3285-4a62-b4df-ab9762f7481f", "average": 230, "high": 260, "low": 200, "units": "NANOMOLAR" }, "type": "INHIBITOR->TARGET", "references": [ "4cb2f3a8-80a0-453f-967b-94edd171c8b9" ], "related_substance": { "uuid": "b822fd8d-e557-4999-a67f-104655c8a9ee", "refuuid": "720e6bd8-9aa7-4473-be81-4438726f64cf", "name": "MDMC", "unii": "L4I4B1R01F", "linking_id": "L4I4B1R01F", "ref_pname": "MDMC", "substance_class": "reference" } }, { "uuid": "08d4707e-c470-4568-a9fb-2805cf8af350", "amount": { "uuid": "e2ea5a83-d7f9-4924-95bd-d21797ede5ba", "average": 680, "high": 810, "low": 550, "units": "NANOMOLAR" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "c8803f60-2d81-4460-8b24-fb7379b9484d", "refuuid": "00947d5e-cd7a-4f6e-a66f-9f4f096fc422", "name": "BUTYLONE", "unii": "X72T4EQ4FQ", "linking_id": "X72T4EQ4FQ", "ref_pname": "BUTYLONE", "substance_class": "reference" } }, { "uuid": "405b66e3-e6c5-40a1-b574-c51ba3c6ef47", "amount": { "uuid": "64933bea-c59e-4cec-9692-52a111850ea3", "average": 330, "high": 370, "low": 290, "units": "NANOMOLAR" }, "comments": "INDUCES SEROTONIN RELEASE; NOT A DAT SUBSTRATE", "qualification": "EC50", "type": "SUBSTRATE->TARGET", "references": [ "e589cb11-c09e-42dd-b0b9-d490a87d3ede" ], "related_substance": { "uuid": "86e0fc43-2f88-46b5-b505-1c8e0639cb80", "refuuid": "00947d5e-cd7a-4f6e-a66f-9f4f096fc422", "name": "BUTYLONE", "unii": "X72T4EQ4FQ", "linking_id": "X72T4EQ4FQ", "ref_pname": "BUTYLONE", "substance_class": "reference" } }, { "uuid": "b78e7a71-a04e-48f1-8eed-38fce5624ad8", "amount": { "uuid": "d8290bc9-2176-401b-9599-cfbfe5de1402" }, "type": "INHIBITOR->TARGET", "references": [ "10737115-99e9-4705-8149-70885179679d" ], "related_substance": { "uuid": "11271267-3edb-4319-800e-cf6ffc95eb1d", "refuuid": "dce3bd0e-2051-4dbe-b4de-bb6b5d88b459", "name": "DA-8031", "unii": "VN9EXL272Y", "linking_id": "VN9EXL272Y", "ref_pname": "DA-8031", "substance_class": "reference" } }, { "uuid": "9bd63b01-76e8-43b2-aa41-94871daa7b83", "amount": { "uuid": "a1508880-f438-434d-909c-5c9ed8ee4b08", "average": 200, "units": "NANOMOLAR" }, "type": "INHIBITOR->OFF-TARGET", "references": [ "5fc4cf14-81ce-4a71-94fb-cab9e1b39616" ], "related_substance": { "uuid": "2017780d-97d0-4709-8fcf-d8cca03ec36a", "refuuid": "d72b31a7-b275-4013-aced-38d7418238af", "name": "4-HYDROXY-N-METHYL-N-ETHYLTRYPTAMINE", "unii": "6RN01B78NY", "linking_id": "6RN01B78NY", "ref_pname": "4-HYDROXY-N-METHYL-N-ETHYLTRYPTAMINE" } }, { "uuid": "5796af5e-83bb-4fc0-9cd6-898d82544035", "amount": { "uuid": "9a0e5fb5-7cd8-4d2e-a652-6f2e13a45245", "average": 2.3, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "fd001928-4877-4241-8f6d-063c89f300c8" ], "related_substance": { "uuid": "b73bf0fd-9591-4dd0-84c9-f4f423057fc5", "refuuid": "8228d5db-c8f9-4a54-9989-8b0316eb1b6f", "name": "LY-367265", "unii": "SS58UXZ8ZU", "linking_id": "SS58UXZ8ZU", "ref_pname": "LY-367265" } }, { "uuid": "5d7a846c-27f0-4d6e-a2b0-8a42001621ff", "amount": { "uuid": "1b404d17-29f2-46a7-a2f0-6e68b396b97b" }, "comments": "STIMULATES SEROTONIN RELEASE.", "type": "SUBSTRATE->TRANSPORTER", "references": [ "4ffc995d-b41f-4a95-9623-2023c5133a64" ], "related_substance": { "uuid": "decce1df-f1dd-4d22-8a6a-00a908f16d86", "refuuid": "76960c91-ffbc-40cd-a862-8a3a858209fd", "name": "FENFLURAMINE", "unii": "2DS058H2CF", "linking_id": "2DS058H2CF", "ref_pname": "FENFLURAMINE" } }, { "uuid": "45ecae30-5279-449a-af60-56b7c3d30a71", "amount": { "uuid": "f5e3a46e-ab9c-4972-9b83-92f11b862064", "average": 208, "high": 255, "low": 161, "units": "NANOMOLAR" }, "comments": "nhibition of [3H]neurotransmitter uptake IC50 ± sem (μΜ).", "qualification": "IC50", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "f74ff704-f4d8-4842-beac-bf4e011e9fec", "refuuid": "f73995c9-9895-441b-821f-f46294e0b783", "name": "TH-PVP", "unii": "S5MU9GV87C", "linking_id": "S5MU9GV87C", "ref_pname": "TH-PVP" } }, { "uuid": "25ce9c11-9671-4379-bfe4-9869f841e77e", "amount": { "uuid": "4a56e304-96fb-4785-a3a2-6f7cc19460c5" }, "type": "LIGAND->TRANSPORTER", "references": [ "d3aad838-652f-4745-bd62-bbe3b753fd55" ], "related_substance": { "uuid": "a5785004-fab6-4677-a2da-48ce55ba1bb8", "refuuid": "b4d065bd-88cb-4900-a865-41f9425bc8f2", "name": "2'-HYDROXYCOCAINE", "unii": "K8J4W658QK", "linking_id": "K8J4W658QK", "ref_pname": "2'-HYDROXYCOCAINE" } }, { "uuid": "f6cee15d-a86a-4a5e-9981-e1fe2b0a241b", "type": "INHIBITOR->TRANSPORTER", "interaction_type": "IN-VITRO", "references": [ "0be91a07-018f-4927-b83d-3b10e79611a6" ], "related_substance": { "uuid": "ae0dcfd1-5451-4dd1-b644-4f7119882a8b", "refuuid": "f7960d9b-4c3b-44c2-9992-3d445eab22df", "name": "RTI-112", "unii": "TDD7WP3S39", "linking_id": "TDD7WP3S39", "ref_pname": "RTI-112" } }, { "uuid": "b7d6ca08-461a-4135-8b1e-5ea7c4e1d89b", "amount": { "uuid": "d514f8cd-112c-42cb-acf2-8629512a3da5" }, "type": "INHIBITOR->TARGET", "references": [ "0d2c035a-4cc0-4484-9511-da244334a585" ], "related_substance": { "uuid": "91894171-34fe-4318-87f4-a878cb3a8957", "refuuid": "d59d483a-00d1-47d1-a53d-3183b2b391e1", "name": "RTI-353", "unii": "ZSB3P8YAZ9", "linking_id": "ZSB3P8YAZ9", "ref_pname": "RTI-353" } }, { "uuid": "605e079a-e754-4951-a297-de7f0c0696d9", "amount": { "uuid": "218e4bff-591c-45bb-b497-7c40c28005cb" }, "comments": " Our data show that drugs known or suspected to increase the risk of PPH (eg, aminorex, fenfluramine, and chlorphentermine) are 5-HT transporter substrates, whereas drugs that have not been shown to increase the risk of PPH are less potent in this regard.", "type": "SUBSTRATE->TRANSPORTER", "references": [ "cfe2f774-563a-4c9e-98cf-85ecf72d09f1" ], "related_substance": { "uuid": "f187c588-c7fa-46e6-9ec9-04b0f8f0abcc", "refuuid": "4e625468-2a89-4f6a-bb0d-e22b7d0488ae", "name": "2C-B-AMINOREX", "unii": "HBY9BQ3YJK", "linking_id": "HBY9BQ3YJK", "ref_pname": "2C-B-AMINOREX" } }, { "uuid": "8a65a934-2d84-4792-b670-4b40ca79c198", "type": "INHIBITOR->TRANSPORTER", "references": [ "2d2ef1d0-6bf2-47af-8de2-b9c6ad1ace0e" ], "related_substance": { "uuid": "51266c60-99ba-4bda-8f6e-d7483b96812a", "refuuid": "b7e7cfcd-a4bb-4f14-ac17-a426a61e9b0c", "name": "PPPA", "unii": "EE55YAQ6HN", "linking_id": "EE55YAQ6HN", "ref_pname": "PPPA" } }, { "uuid": "0ce33e45-fca5-485e-ba23-edadbfa9fb06", "amount": { "uuid": "97ca200e-061d-40ee-8d1d-70630302d261" }, "type": "INHIBITOR->TRANSPORTER", "references": [ "853322d2-e641-4da6-8184-46e31c1698e9" ], "related_substance": { "uuid": "cc95f126-1805-4b1d-bfda-070fee199009", "refuuid": "5c8cd4e5-b279-48ae-af3a-d26a83ddf84e", "name": "PRC200-SS", "unii": "V9MLT2S334", "linking_id": "V9MLT2S334", "ref_pname": "PRC200-SS" } }, { "uuid": "67dcaf5b-13fd-449c-bc05-dabbd58539df", "amount": { "uuid": "75517ecc-33ec-4d1d-b3f7-1ffe52357f15" }, "type": "INHIBITOR->TRANSPORTER", "references": [ "3380b426-e05a-4a2a-b875-91127f37e490" ], "related_substance": { "uuid": "19bd608b-48c6-415a-888a-e24b81670978", "refuuid": "8cfbe220-5321-436d-8c54-cc19d68ca0c6", "name": "CYANODOTHIEPIN", "unii": "KK5VES2GLD", "linking_id": "KK5VES2GLD", "ref_pname": "CYANODOTHIEPIN" } }, { "uuid": "58c53974-56d0-4f2e-871c-77000ebab6b0", "amount": { "uuid": "ca418b80-b401-4d21-b11e-ff9101bb9896" }, "type": "LIGAND->TRANSPORTER", "references": [ "d4768f98-e05c-4e58-86d7-3958dbfee941" ], "related_substance": { "uuid": "f2f5cea0-83a4-44e7-b761-6602dfc70d84", "refuuid": "00ab6bd1-0577-4203-ac17-9682c591bfd9", "name": "RTI-177", "unii": "8VL7AW8T35", "linking_id": "8VL7AW8T35", "ref_pname": "RTI-177" } }, { "uuid": "a139f8e5-240c-4508-a2bf-beffb58880f1", "amount": { "uuid": "ebca691f-c3a5-43b7-935f-73c32876729c" }, "type": "INHIBITOR->TRANSPORTER", "references": [ "129ba18a-791e-4428-9e8f-8a822fc30620" ], "related_substance": { "uuid": "a7c1c5ac-9004-4f1c-8dcf-091730aaa391", "refuuid": "e2e779e7-5614-4256-86f6-6e20680992f4", "name": "N-METHYL-PPPA", "unii": "C6C3GB68TV", "linking_id": "C6C3GB68TV", "ref_pname": "N-METHYL-PPPA" } }, { "uuid": "ff82db04-b3fa-4e1e-93ea-792255f9f27a", "amount": { "uuid": "edbcff9a-5d4a-4f0f-ad71-be71402afbe2", "average": 42, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "6c2fbf58-b1a5-468d-96ec-d01a5a3dcb1b" ], "related_substance": { "uuid": "83c50810-fe53-4428-ae50-79059b4af918", "refuuid": "57adca1d-724b-4341-82a9-0b90a07efc01", "name": "BGC-20-1259", "unii": "Y73947J3R5", "linking_id": "Y73947J3R5", "ref_pname": "BGC-20-1259", "substance_class": "reference" } }, { "uuid": "ea0d8410-50e4-4362-b68e-3d9d600e209f", "amount": { "uuid": "5aec6634-4b02-4210-b9d8-41957dbf58e4", "average": 1.7, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "RADIOLIGAND->TARGET", "references": [ "3f8ddf2e-84cc-49d9-b4c5-90f61421b34a" ], "related_substance": { "uuid": "3b525f47-3b6f-47f8-a872-f0b28923b20d", "refuuid": "57483610-e067-4818-b2f1-d7949b8f35e9", "name": "Imipramine H-3", "unii": "DB7S4QSS89", "linking_id": "DB7S4QSS89", "ref_pname": "Imipramine H-3", "substance_class": "reference" } }, { "uuid": "1742add7-9967-4a54-8c99-0f4920a6931a", "amount": { "uuid": "5be084fa-e09e-4334-87f1-2bdd3891b2bc" }, "type": "INHIBITOR->TARGET", "references": [ "922531c6-aab5-4938-a713-40e17ff24c32", "35a3a456-778d-4d4f-b9cd-dc2c473f0849" ], "related_substance": { "uuid": "d553054e-b5c1-4521-9f3a-65195077ec0c", "refuuid": "5ac90935-e4f7-42d1-b121-cbd0dfd198ed", "name": "RO-15-8081 FREE BASE", "unii": "J6EIG6Q478", "linking_id": "J6EIG6Q478", "ref_pname": "RO-15-8081 FREE BASE", "substance_class": "reference" } }, { "uuid": "0c344506-886c-4c8b-863c-c7ec0508647a", "amount": { "uuid": "ebf1fba1-6aaa-4300-88d3-166e1202bd8f", "average": 3.6, "units": "MICROMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "interaction_type": "BINDING", "references": [ "b72b4d6d-a2c2-438f-9cff-e5cdb5986703" ], "related_substance": { "uuid": "45efc25f-844e-4468-adb0-ccd3bad987af", "refuuid": "96bfe779-668a-4b4b-afbd-db9c2cd59abc", "name": "ZIMELDINE", "unii": "3J928617DW", "linking_id": "3J928617DW", "ref_pname": "ZIMELDINE", "substance_class": "reference" } }, { "uuid": "8a2c1c68-9229-44fe-86d0-12c5eaae1a3a", "amount": { "uuid": "3393d272-7376-4b0e-adf3-f8ad9e03df48", "average": 2698, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "WEAK INHIBITOR->TARGET", "related_substance": { "uuid": "c11d65c3-c322-4e42-a3cb-6f0ed9af2778", "refuuid": "6c35f9c2-7ba4-488a-963f-aa8b8fc3f49e", "name": "6-APB", "unii": "285VE60914", "linking_id": "285VE60914", "ref_pname": "6-APB", "substance_class": "reference" } }, { "uuid": "7fa25326-79ba-457d-9138-4a688a8726dd", "amount": { "uuid": "1d56f681-a861-4968-a8ae-ae08026271c1" }, "comments": "From Rat Membrane Studies", "type": "INHIBITOR->TARGET", "references": [ "4e348888-06c2-41f7-8691-8b63cf93dc5c" ], "related_substance": { "uuid": "9390bc6e-1d00-4065-8307-bde22738e81c", "refuuid": "4fe94e42-f1d1-4d3a-97a1-7dc930c965df", "name": "INDOPAN", "unii": "BIK35ACJ0Q", "linking_id": "BIK35ACJ0Q", "ref_pname": "INDOPAN", "substance_class": "reference" } }, { "uuid": "019d5703-f9c9-45ca-b668-d3263b1a78cc", "amount": { "uuid": "355749e0-d614-4fee-84d6-01843e7d3be4", "high": 40, "low": 23, "units": "NANOMOLAR" }, "comments": "Rat", "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "b3af0f7c-6a0f-49e1-be9d-91949b419996" ], "related_substance": { "uuid": "4a616b52-a42d-4c63-b141-fdd99c9ff950", "refuuid": "18e34494-7681-4990-aa38-cf7c8d40bce1", "name": "Dextromethorphan", "unii": "7355X3ROTS", "linking_id": "7355X3ROTS", "ref_pname": "Dextromethorphan", "substance_class": "reference" } }, { "uuid": "b92e643e-7dbe-405f-9a06-4e3c6ddfa72d", "amount": { "uuid": "20fbac8c-efb1-491b-b1c1-a2f8ac8117d5", "average": 47.3, "high": 66.7, "low": 27.9, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "250b96b7-c705-4ac5-a00a-f2126ad9bfb8", "refuuid": "eb2e8a38-528a-4b49-9dba-f7af328d3996", "name": "DESVENLAFAXINE", "unii": "NG99554ANW", "linking_id": "NG99554ANW", "ref_pname": "DESVENLAFAXINE", "substance_class": "reference" } }, { "uuid": "8a5fd24d-091f-462a-b20c-4b9313639c67", "amount": { "uuid": "c522479d-828c-4539-b2b1-b5029206454b" }, "type": "INHIBITOR->TARGET", "references": [ "59b5c977-9c32-4ced-8f6f-b3527a480103" ], "related_substance": { "uuid": "aa592bfd-f6f6-4da9-98d0-09e5e22164e9", "refuuid": "9f570f75-a598-42d3-bc95-9fa5c6346322", "name": "PSN-602", "unii": "B27VXE4GHR", "linking_id": "B27VXE4GHR", "ref_pname": "PSN-602", "substance_class": "reference" } }, { "uuid": "d1a7a7f5-66fc-4679-91cb-8146e0ce48bb", "amount": { "uuid": "189a9f73-c729-448a-99c5-d148dbb0844f" }, "type": "INHIBITOR->TARGET", "references": [ "77cfb344-31ec-432a-b182-27abaa5f7529" ], "related_substance": { "uuid": "75afbcaa-c3eb-4c6a-ab44-e5fe348cbe63", "refuuid": "56e60af8-bd89-4c43-8191-1bb8876639f0", "name": "UK-390957", "unii": "W26I0D1D6J", "linking_id": "W26I0D1D6J", "ref_pname": "UK-390957", "substance_class": "reference" } }, { "uuid": "e79367a6-e2d1-48cb-8d61-fb67c26ae8a3", "amount": { "uuid": "38b058a1-1328-4820-97b6-5e9f1f66dfd0" }, "type": "INHIBITOR->TARGET", "references": [ "3781604e-d364-4a57-b923-9ca266dde09c" ], "related_substance": { "uuid": "5f7352dd-43df-4d2c-9f62-09ccd59aa4e2", "refuuid": "062e75f2-b72d-4e09-8608-c41105b96bff", "name": "DESVENLAFAXINE, (-)-", "unii": "HY5T9WKI4O", "linking_id": "HY5T9WKI4O", "ref_pname": "DESVENLAFAXINE, (-)-", "substance_class": "reference" } }, { "uuid": "7056271a-8935-421a-a440-30981430b56f", "amount": { "uuid": "63794523-66ea-4212-94e5-c678f5aead3a", "average": 9.5, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "3b239291-368a-4294-89db-295b5085cdd4" ], "related_substance": { "uuid": "6934e85a-d926-4658-9278-fa4dd773a1f7", "refuuid": "705c5821-34b5-4933-ae24-86e7efbe23dc", "name": "Pudafensine", "unii": "L9NG7US8GE", "linking_id": "L9NG7US8GE", "ref_pname": "Pudafensine", "substance_class": "reference" } }, { "uuid": "a46a17ee-a240-48b2-b8df-85ca218b1183", "amount": { "uuid": "63f44187-dc0a-400f-90ee-977ffb358582" }, "comments": "Based on impramine", "type": "INHIBITOR->TARGET", "references": [ "85b2b544-76bb-4c5c-896b-7a3f2e0c6946", "b2f05544-2163-4f6b-97c2-c553d3c799e0" ], "related_substance": { "uuid": "05510812-e3ab-4fb4-bc46-d22aba272851", "refuuid": "abd095af-8412-4c88-bc37-f3d1b5546297", "name": "Ro-035939 free base", "unii": "Q362RQ92NG", "linking_id": "Q362RQ92NG", "ref_pname": "Ro-035939 free base", "substance_class": "reference" } }, { "uuid": "ce18097d-5ea4-4ecb-895f-5d5c4e3e2937", "amount": { "uuid": "a63b5da0-dba8-4a20-9eda-6bac9c8ab572" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "b5a2768d-2b0f-468a-a1d0-2a4f0857f4be", "refuuid": "159bbede-e616-4bc5-9127-f7e20962330a", "name": "Stacofylline", "unii": "C7K8PK4Q0E", "linking_id": "C7K8PK4Q0E", "ref_pname": "Stacofylline", "substance_class": "reference" } }, { "uuid": "7c2aee12-cbac-4073-bd57-14c910faf009", "amount": { "uuid": "b003db38-2697-41d3-a414-d116c345c886", "average": 0.6, "units": "MICROMOLAR" }, "qualification": "IC50", "type": "LIGAND->OFF TARGET", "related_substance": { "uuid": "33dbf84b-a2da-488c-8f64-e97cca2f57ad", "refuuid": "f66c88a8-735d-43a6-bc37-58a692a880c6", "name": "Siponimod", "unii": "RR6P8L282I", "linking_id": "RR6P8L282I", "ref_pname": "Siponimod", "substance_class": "reference" } }, { "uuid": "25cd9719-9fd1-4076-af82-aed74f6a568f", "amount": { "uuid": "d5efa7d1-e49b-47e8-9faf-ca8602ab55d8" }, "type": "INHIBITOR->TARGET", "references": [ "1c8ac9f5-f10f-4417-9bfd-f72254544bbb" ], "related_substance": { "uuid": "b2bb06db-cc58-41a4-8585-cab8901ab6dd", "refuuid": "0aa12195-b070-405b-bcae-0174c9c61fec", "name": "EXP-561", "unii": "1P958G9T1V", "linking_id": "1P958G9T1V", "ref_pname": "EXP-561", "substance_class": "reference" } }, { "uuid": "bc42603d-4db9-40a5-aa18-6fbe84d216ab", "amount": { "uuid": "078d26d1-6ca8-4d14-9f12-65780fea9dfb", "average": 4740, "high": 4968, "low": 4512, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "27ba7b34-2d52-4557-ae4b-db6a700bb367" ], "related_substance": { "uuid": "3107d90d-9566-4ad7-82f3-7e6fd143bc31", "refuuid": "ae714a7d-2ed8-459e-b776-7f6c6db4afe7", "name": "MIDOMAFETAMINE, (R)-", "unii": "3947754WXW", "linking_id": "3947754WXW", "ref_pname": "MIDOMAFETAMINE, (R)-", "substance_class": "reference" } } ], "names": [ { "uuid": "f8f98940-f2fe-4157-df9c-1f1f1c6efe2d", "name": "5HT TRANSPORTER", "stdName": "5HT TRANSPORTER", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d227128-7c20-f4d0-044a-71de66f8e581" ], "display_name": false }, { "uuid": "24a00b66-34cb-41fb-dd99-3e141ba36637", "name": "5HTT", "stdName": "5HTT", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d227128-7c20-f4d0-044a-71de66f8e581" ], "display_name": false }, { "uuid": "758f564d-75f8-7462-379b-e8ee616a3dc7", "name": "HTT", "stdName": "HTT", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d227128-7c20-f4d0-044a-71de66f8e581" ], "display_name": false }, { "uuid": "7fadb37a-12b1-6d0d-4565-64894fdfd4d3", "name": "SEROTONIN REUPTAKE TRANSPORTER", "stdName": "SEROTONIN REUPTAKE TRANSPORTER", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "8eed7d72-e185-44cf-a4d7-638fbdf8b809" ], "display_name": false }, { "uuid": "2abd5d99-b5da-c1c9-4825-bf021019e819", "name": "SERT", "stdName": "SERT", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d227128-7c20-f4d0-044a-71de66f8e581" ], "display_name": false }, { "uuid": "6efebfaf-3423-b087-f4df-578d96ecd177", "name": "SLC6A4", "stdName": "SLC6A4", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d227128-7c20-f4d0-044a-71de66f8e581" ], "display_name": false }, { "uuid": "79e0b498-2a79-44c5-bf07-3331309b1344", "name": "SODIUM-DEPENDENT SEROTONIN TRANSPORTER", "stdName": "SODIUM-DEPENDENT SEROTONIN TRANSPORTER", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d227128-7c20-f4d0-044a-71de66f8e581" ], "display_name": true }, { "uuid": "3845151f-d554-22e8-8450-f8058d0b156e", "name": "SOLUTE CARRIER FAMILY 6 MEMBER 4", "stdName": "SOLUTE CARRIER FAMILY 6 MEMBER 4", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d227128-7c20-f4d0-044a-71de66f8e581" ], "display_name": false } ], "protein": { "uuid": "05b3169d-ec49-4d78-bf9e-035612a3c54c", "glycosylation": { "uuid": "200c93c1-f421-4d64-8a4e-280bbe0cf765", "glycosylation_type": "HUMAN", "n_glycosylation_sites": [ { "residue_index": 208, "subunit_index": 1 }, { "residue_index": 217, "subunit_index": 1 } ] }, "subunits": [ { "uuid": "ef0273b6-090f-4f2f-a4c6-ba607bc7a448", "sequence": "METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV", "subunit_index": 1 } ], "references": [ "2d227128-7c20-f4d0-044a-71de66f8e581" ], "disulfide_links": [ { "sites": [ { "residue_index": 200, "subunit_index": 1 }, { "residue_index": 209, "subunit_index": 1 } ] } ], "protein_sub_type": "REUPTAKE RECEPTOR", "protein_type": "RECEPTOR", "sequence_origin": "HUMAN", "sequence_type": "COMPLETE" }, "properties": [ { "uuid": "baa6a556-24bc-4d0e-a535-10db1f2717da", "name": "MOL_WEIGHT:NUMBER(CALCULATED)", "type": "amount", "value": { "uuid": "471b89cb-4bf6-4ca0-9dda-43e2a3d0f15c", "type": "ESTIMATED", "average": 70300, "units": "Da" }, "defining": false, "property_type": "CHEMICAL" } ], "modifications": { "uuid": "100e2098-20d2-4a8b-9d50-6bab5c0e59b9", "structural_modifications": [ { "uuid": "3531404d-2b1f-47f6-afa6-ca7275e6cca3", "sites": [ { "residue_index": 47, "subunit_index": 1 }, { "residue_index": 142, "subunit_index": 1 } ], "location_type": "SITE_SPECIFIC", "molecular_fragment": { "uuid": "5a5a664c-8a4c-4e73-bdda-8be3c337d0a3", "refuuid": "6534bbf5-6eb4-4a29-aba8-46e6ed9c50bd", "name": "TYROSINE O-PHOSPHATE", "unii": "2R86C98KDX", "linking_id": "2R86C98KDX", "ref_pname": "TYROSINE O-PHOSPHATE", "substance_class": "reference" }, "structural_modification_type": "AMINO_ACID_SUBSTITUTION" }, { "uuid": "d0d455df-9017-4bfb-8a8a-0c9e395de558", "sites": [ { "residue_index": 613, "subunit_index": 1 }, { "residue_index": 616, "subunit_index": 1 } ], "location_type": "SITE_SPECIFIC", "molecular_fragment": { "uuid": "ec07d873-aaf7-4e92-9be9-4ad39a8f3eb2", "refuuid": "96bbf36a-d049-4313-9712-8608530faef7", "name": "THREONINE PHOSPHATE", "unii": "3L4WX7B1EI", "linking_id": "3L4WX7B1EI", "ref_pname": "THREONINE PHOSPHATE", "substance_class": "reference" }, "structural_modification_type": "AMINO_ACID_SUBSTITUTION" }, { "uuid": "19d91928-2139-4e5a-b72d-511603486ee7", "sites": [ { "residue_index": 611, "subunit_index": 1 } ], "location_type": "SITE_SPECIFIC", "molecular_fragment": { "uuid": "f3eb249f-f567-430c-9892-0804e9265521", "refuuid": "b6eb2edb-1b4d-46ad-92ad-a43f0f545926", "name": "DEXFOSFOSERINE", "unii": "VI4F0K069V", "linking_id": "VI4F0K069V", "ref_pname": "DEXFOSFOSERINE", "substance_class": "reference" }, "structural_modification_type": "AMINO_ACID_SUBSTITUTION" } ] } } ] }